Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.06% Nasdaq Down0.01%

BioSante Pharmaceuticals, Inc. (BPAX)

-NasdaqGM

1.24 Up 0.09(7.83%) May 24, 4:00PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 30, 2012Dec 30, 2011Dec 30, 2010
Total Revenue 2,301   435   2,474  
Cost of Revenue95  50  269  
Gross Profit 2,206   385   2,205  
Operating Expenses
Research Development16,889  44,182  39,706  
Selling General and Administrative8,230  6,981  5,940  
Non Recurring -   -   -  
Others259  148  168  
Total Operating Expenses -   -   -  
Operating Income or Loss (23,172) (50,927) (43,608)
Income from Continuing Operations
Total Other Income/Expenses Net(4,320)(0)(1,900)
Earnings Before Interest And Taxes(27,492)(50,927)(45,508)
Interest Expense348  682  688  
Income Before Tax(27,840)(51,609)(46,196)
Income Tax Expense(122) -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(27,718)(51,609)(46,196)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (27,718) (51,609) (46,196)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (27,718) (51,609) (46,196)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.